Published in Obesity and Diabetes Week, April 24th, 2006
"We are very pleased the FDA has approved the DexCom STS Continuous Glucose Monitoring Product and are hopeful this novel technology will improve the quality of life for people living with diabetes," said Andrew P. Rasdal, DexCom president and chief executive officer.
The DexCom STS consists of a tiny wire-like sensor that is inserted by the patient just under the skin. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week